Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
Rozalina G. McCoy, Jeph Herrin, Kavya Swarna, Yihong Deng, David M. Kent, Joseph S. Ross, Guillermo E. Umpierrez, Rodolfo J. Galindo, William H. Crown, Bijan J. Borah, Víctor M. Montori, Juan P. Brito, Joshua J. Neumiller, Mindy M. Mickelson, Eric C. Polley
Topics & Concepts
Type 2 diabetesMedicineDiabetes mellitusInternal medicineCardiologyEndocrinologyDiabetes Treatment and ManagementDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins